Clinical Trial

Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors

Name: Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors — clinical trial record (NCT06950086)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study is to evaluate the safety, pharmacokinetics, and preliminary antitumor activity of TYK-00540 as monotherapy or combined with fulvestrant in advanced solid tumors.

Trial Details

NCT Number	NCT06950086
Lead Sponsor	TYK Medicines, Inc
Conditions	HR-positive, HER2-negative Advanced Breast Cancer
Enrollment	180 participants
Start Date	2024-01-02
Primary Completion	2026-09 (estimated)
Study Completion	2026-11 (estimated)
Updated on ClinicalTrials.gov	2025-04-29